Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Genetic Counseling
|
March 12, 2017
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer
G Cicero, R De Luca, P Dorangricchia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
Founder mutations in BRCA1 and BRCA2 genes
R Ferla, V Calò, S Cascio, et al.
Metallomics : Integrated Biometal Science
|
November 24, 2015
Copper binding to naturally occurring, lactam form of angiogenin differs from that to recombinant protein, affecting their activity
D La Mendola, F Arnesano, Ö Hansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability
S Veschi, G Aceto, A P Scioletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2005
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study
V Bazan, V Agnese, S Corsale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
C Augello, L Bruno, V Bazan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily)
A Russo, V Calò, C Augello, et al.
ESMO Open
|
August 9, 2021
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge
M Bono, D Fanale, L Incorvaia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
V Bazan, L Bruno, C Augello, et al.
Journal of Cancer Research and Clinical Oncology
|
December 11, 2002
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study
V Bazan, M Migliavacca, I Zanna, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Genetic Counseling
|
March 12, 2017
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer
G Cicero, R De Luca, P Dorangricchia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
Founder mutations in BRCA1 and BRCA2 genes
R Ferla, V Calò, S Cascio, et al.
Metallomics : Integrated Biometal Science
|
November 24, 2015
Copper binding to naturally occurring, lactam form of angiogenin differs from that to recombinant protein, affecting their activity
D La Mendola, F Arnesano, Ö Hansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability
S Veschi, G Aceto, A P Scioletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2005
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study
V Bazan, V Agnese, S Corsale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
C Augello, L Bruno, V Bazan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily)
A Russo, V Calò, C Augello, et al.
ESMO Open
|
August 9, 2021
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge
M Bono, D Fanale, L Incorvaia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
V Bazan, L Bruno, C Augello, et al.
Journal of Cancer Research and Clinical Oncology
|
December 11, 2002
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study
V Bazan, M Migliavacca, I Zanna, et al.
Page
of 2